Home › Companies › Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Medical › InterVenn
InterVenn
InterVenn unlocks the glycoproteome using artificial intelligence for the development of transformational healthcare solutions in DX and Rx.
InterVenn is a company in artificial intelligence (ai), biotechnology, health care, life science, medical based in San Francisco Bay Area, West Coast, Western US, founded in 2017.
InterVenn is positioned in artificial intelligence (ai), biotechnology, health care, life science, medical, a segment that rewards a clear, focused offering.
San Francisco Bay Area, West Coast, Western US is where the company is located.
It is recorded at the Series_C stage.
The company reports a headcount in the c_00101_00250 range.
Total disclosed funding stands at about $278.1M.
| Sector | Artificial Intelligence (AI), Biotechnology, Health Care, Life Science, Medical |
|---|---|
| Headquarters | San Francisco Bay Area, West Coast, Western US |
| Country | US |
| Founded | 2017 |
| Employees | c_00101_00250 |
| Stage | series_c |
| Total funding | $278,089,885 |
Website: intervenn.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account